Raymond James Financial Inc. Takes Position in Addus HomeCare Co. (NASDAQ:ADUS)

Raymond James Financial Inc. bought a new stake in Addus HomeCare Co. (NASDAQ:ADUS) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 52,948 shares of the company’s stock, valued at approximately $6,637,000. Raymond James Financial Inc. owned about 0.29% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Wasatch Advisors LP raised its stake in Addus HomeCare by 11.8% during the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after acquiring an additional 110,010 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after acquiring an additional 78,835 shares during the last quarter. Principal Financial Group Inc. raised its stake in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Barclays PLC raised its stake in Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after acquiring an additional 29,207 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Addus HomeCare by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock valued at $56,406,000 after acquiring an additional 28,284 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Price Performance

ADUS opened at $89.83 on Monday. The stock has a market cap of $1.63 billion, a P/E ratio of 20.56, a P/E/G ratio of 1.41 and a beta of 0.97. The stock’s 50 day simple moving average is $111.83 and its 200 day simple moving average is $121.75. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. JMP Securities assumed coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price on the stock. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Finally, Macquarie reiterated an “outperform” rating and set a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average target price of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.